In addition to the high expression level of TRH in AML, only ovarian serous cystadenocarcinoma (OV) had a significantly differential expression of TRH compared with the normal ovaries (p < 0.05) (Figure 1). This evidence concerns the gene TRH and acute myeloid leukemia.